Immunizations and risk of multiple sclerosis: Systematic review and meta-analysis

The role of vaccinations in risk of developing multiple sclerosis (MS) or in risk of relapse has not been well established. The aim of this study was to estimate the effect of immunizations on risk of developing MS in adults as well as in subsequent risk of relapse. Systematic search for publication...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado: 2011
Materias:
Acceso en línea:https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_03405354_v258_n7_p1197_Farez
http://hdl.handle.net/20.500.12110/paper_03405354_v258_n7_p1197_Farez
Aporte de:
id paper:paper_03405354_v258_n7_p1197_Farez
record_format dspace
spelling paper:paper_03405354_v258_n7_p1197_Farez2023-06-08T15:33:58Z Immunizations and risk of multiple sclerosis: Systematic review and meta-analysis Meta-analysis Multiple sclerosis Systematic review Vaccines BCG vaccine chickenpox vaccine diphtheria pertussis tetanus vaccine diphtheria toxoid hepatitis A vaccine hepatitis B vaccine influenza vaccine measles mumps rubella vaccine poliomyelitis vaccine tetanus toxoid typhoid vaccine BCG vaccination chickenpox data base diphtheria drug efficacy hepatitis A hepatitis B human immunization influenza influenza vaccination measles measles vaccination meta analysis multiple sclerosis mumps outcome assessment pertussis poliomyelitis priority journal randomized controlled trial (topic) relapse review risk factor rubella systematic review tetanus tetanus prophylaxis treatment outcome tuberculosis typhoid fever Humans Immunization Multiple Sclerosis Risk The role of vaccinations in risk of developing multiple sclerosis (MS) or in risk of relapse has not been well established. The aim of this study was to estimate the effect of immunizations on risk of developing MS in adults as well as in subsequent risk of relapse. Systematic search for publications in MEDLINE (1966-January 2011), EMBASE (1977-January 2011) and the Cochrane Central Register of Controlled Trials (CENTRAL) (1961-January 2011). Both randomized clinical trials and non-randomized studies addressing the effect of any Center for Diseases Control (CDC) recommended vaccine for children, adults or travelers and BCG on risk of MS or disease relapse were included. Two reviewers independently extracted information from articles selected using a predefined datasheet. No significant change in the risk of developing MS after vaccination was found for BCG (OR 0.96, 95% CI 0.69-1.34), Hepatitis B (OR 1.00, 95% CI 0.74-1.37), Influenza (OR 0.97, 95% CI 0.77-1.23), Measles-Mumps-Rubella (MMR) (OR 1.02, 95% CI 0.64-1.61), Polio (OR 0.87, 95% CI 0.61-1.25) and Typhoid fever (OR 1.05, 95% CI 0.72-1.53). We found decreased risk of developing MS for Diphtheria (OR 0.60, 95% CI 0.40-0.90) and Tetanus (OR 0.68, 95% CI 0.54-0.84). Influenza immunization was also associated with no change in risk of MS relapse (RR 1.24, 95% CI 0.89-1.72). Risk of developing multiple sclerosis remained unchanged after BCG, Hepatitis B, Influenza, MMR, Polio and Typhoid fever immunization, whereas diphtheria and tetanus vaccination may be associated with a decreased risk of MS. Further research is needed for the remaining vaccines. © 2011 Springer-Verlag. 2011 https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_03405354_v258_n7_p1197_Farez http://hdl.handle.net/20.500.12110/paper_03405354_v258_n7_p1197_Farez
institution Universidad de Buenos Aires
institution_str I-28
repository_str R-134
collection Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA)
topic Meta-analysis
Multiple sclerosis
Systematic review
Vaccines
BCG vaccine
chickenpox vaccine
diphtheria pertussis tetanus vaccine
diphtheria toxoid
hepatitis A vaccine
hepatitis B vaccine
influenza vaccine
measles mumps rubella vaccine
poliomyelitis vaccine
tetanus toxoid
typhoid vaccine
BCG vaccination
chickenpox
data base
diphtheria
drug efficacy
hepatitis A
hepatitis B
human
immunization
influenza
influenza vaccination
measles
measles vaccination
meta analysis
multiple sclerosis
mumps
outcome assessment
pertussis
poliomyelitis
priority journal
randomized controlled trial (topic)
relapse
review
risk factor
rubella
systematic review
tetanus
tetanus prophylaxis
treatment outcome
tuberculosis
typhoid fever
Humans
Immunization
Multiple Sclerosis
Risk
spellingShingle Meta-analysis
Multiple sclerosis
Systematic review
Vaccines
BCG vaccine
chickenpox vaccine
diphtheria pertussis tetanus vaccine
diphtheria toxoid
hepatitis A vaccine
hepatitis B vaccine
influenza vaccine
measles mumps rubella vaccine
poliomyelitis vaccine
tetanus toxoid
typhoid vaccine
BCG vaccination
chickenpox
data base
diphtheria
drug efficacy
hepatitis A
hepatitis B
human
immunization
influenza
influenza vaccination
measles
measles vaccination
meta analysis
multiple sclerosis
mumps
outcome assessment
pertussis
poliomyelitis
priority journal
randomized controlled trial (topic)
relapse
review
risk factor
rubella
systematic review
tetanus
tetanus prophylaxis
treatment outcome
tuberculosis
typhoid fever
Humans
Immunization
Multiple Sclerosis
Risk
Immunizations and risk of multiple sclerosis: Systematic review and meta-analysis
topic_facet Meta-analysis
Multiple sclerosis
Systematic review
Vaccines
BCG vaccine
chickenpox vaccine
diphtheria pertussis tetanus vaccine
diphtheria toxoid
hepatitis A vaccine
hepatitis B vaccine
influenza vaccine
measles mumps rubella vaccine
poliomyelitis vaccine
tetanus toxoid
typhoid vaccine
BCG vaccination
chickenpox
data base
diphtheria
drug efficacy
hepatitis A
hepatitis B
human
immunization
influenza
influenza vaccination
measles
measles vaccination
meta analysis
multiple sclerosis
mumps
outcome assessment
pertussis
poliomyelitis
priority journal
randomized controlled trial (topic)
relapse
review
risk factor
rubella
systematic review
tetanus
tetanus prophylaxis
treatment outcome
tuberculosis
typhoid fever
Humans
Immunization
Multiple Sclerosis
Risk
description The role of vaccinations in risk of developing multiple sclerosis (MS) or in risk of relapse has not been well established. The aim of this study was to estimate the effect of immunizations on risk of developing MS in adults as well as in subsequent risk of relapse. Systematic search for publications in MEDLINE (1966-January 2011), EMBASE (1977-January 2011) and the Cochrane Central Register of Controlled Trials (CENTRAL) (1961-January 2011). Both randomized clinical trials and non-randomized studies addressing the effect of any Center for Diseases Control (CDC) recommended vaccine for children, adults or travelers and BCG on risk of MS or disease relapse were included. Two reviewers independently extracted information from articles selected using a predefined datasheet. No significant change in the risk of developing MS after vaccination was found for BCG (OR 0.96, 95% CI 0.69-1.34), Hepatitis B (OR 1.00, 95% CI 0.74-1.37), Influenza (OR 0.97, 95% CI 0.77-1.23), Measles-Mumps-Rubella (MMR) (OR 1.02, 95% CI 0.64-1.61), Polio (OR 0.87, 95% CI 0.61-1.25) and Typhoid fever (OR 1.05, 95% CI 0.72-1.53). We found decreased risk of developing MS for Diphtheria (OR 0.60, 95% CI 0.40-0.90) and Tetanus (OR 0.68, 95% CI 0.54-0.84). Influenza immunization was also associated with no change in risk of MS relapse (RR 1.24, 95% CI 0.89-1.72). Risk of developing multiple sclerosis remained unchanged after BCG, Hepatitis B, Influenza, MMR, Polio and Typhoid fever immunization, whereas diphtheria and tetanus vaccination may be associated with a decreased risk of MS. Further research is needed for the remaining vaccines. © 2011 Springer-Verlag.
title Immunizations and risk of multiple sclerosis: Systematic review and meta-analysis
title_short Immunizations and risk of multiple sclerosis: Systematic review and meta-analysis
title_full Immunizations and risk of multiple sclerosis: Systematic review and meta-analysis
title_fullStr Immunizations and risk of multiple sclerosis: Systematic review and meta-analysis
title_full_unstemmed Immunizations and risk of multiple sclerosis: Systematic review and meta-analysis
title_sort immunizations and risk of multiple sclerosis: systematic review and meta-analysis
publishDate 2011
url https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_03405354_v258_n7_p1197_Farez
http://hdl.handle.net/20.500.12110/paper_03405354_v258_n7_p1197_Farez
_version_ 1768545418717691904